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Abstract
Objective: Disturbances in lipid metabolism are strongly associated with insulin resistance and type 2 diabetes (T2D). We
hypothesized that activation of cAMP/PKA and calcium signaling pathways in cultured human myotubes would provide
further insight into regulation of lipid storage, lipolysis, lipid oxidation and insulin responsiveness.
Methods: Human myoblasts were isolated from vastus lateralis, purified, cultured and differentiated into myotubes. All cells
were incubated with palmitate during differentiation. Treatment cells were pulsed 1 hour each day with forskolin and
ionomycin (PFI) during the final 3 days of differentiation to activate the cAMP/PKA and calcium signaling pathways. Control
cells were not pulsed (control). Mitochondrial content,
14C lipid oxidation and storage were measured, as well as lipolysis
and insulin-stimulated glycogen storage. Myotubes were stained for lipids and gene expression measured.
Results: PFI increased oxidation of oleate and palmitate to CO2 (p,0.001), isoproterenol-stimulated lipolysis (p=0.01),
triacylglycerol (TAG) storage (p,0.05) and mitochondrial DNA copy number (p=0.01) and related enzyme activities.
Candidate gene and microarray analysis revealed increased expression of genes involved in lipolysis, TAG synthesis and
mitochondrial biogenesis. PFI increased the organization of lipid droplets along the myofibrillar apparatus. These changes in
lipid metabolism were associated with an increase in insulin-mediated glycogen storage (p,0.001).
Conclusions: Activation of cAMP/PKA and calcium signaling pathways in myotubes induces a remodeling of lipid droplets
and functional changes in lipid metabolism. These results provide a novel pharmacological approach to promote lipid
metabolism and improve insulin responsiveness in myotubes, which may be of therapeutic importance for obesity and type
2 diabetes.
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Introduction
Insulin resistance is a common feature of obesity, metabolic
syndrome and atherosclerosis [1,2]. Insulin resistance, which can
be defined as a state of reduced responsiveness to normal
physiological levels of insulin regarding both glucose [3] and fatty
acid [4,5] utilization, plays a major role in the development of type
2 diabetes mellitus (T2DM). Skeletal muscle is critical for glucose
disposal in vivo [6]. In this respect, skeletal muscle insulin resistance
is a strong determinant of T2DM, thus making improvements in
insulin responsiveness a nominal feature of its treatment and
prevention.
In the last 10 years, a ‘‘lipocentric’’ view of insulin resistance has
gained attention. Abnormalities in fatty acid metabolism may
result in the inappropriate accumulation of lipids in skeletal
muscle, liver, heart and b-cells [7,8]. This ‘‘ectopic’’ fat deposition,
e.g. the accumulation of intramyocellular triacylglycerols (IMTG),
has been associated with skeletal muscle insulin resistance
(extensively reviewed in [9,10,11,12]). IMTG content is increased
in skeletal muscle of sedentary populations including individuals
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stimulated glucose disposal [13]. An imbalance between free fatty
acid (FFA) availability and lipid oxidation is of primary importance
in the development of skeletal muscle insulin resistance.
Paradoxically, IMTG content is increased in highly insulin
sensitive endurance-trained subjects, suggesting that IMTG per se
are not causative in skeletal muscle insulin resistance [14]. IMTG
content is probably a marker for accumulation of other lipid
intermediates (fatty acyl-CoA, diacylglycerol, ceramides and lipid
peroxidation products), each with the potential to interfere with
insulin signaling and glucose metabolism. These lipid intermedi-
ates activate several downstream targets such as PKCh and the
NFkB pathway, thus altering the insulin receptor, insulin receptor
substrate 1 (IRS1) and phosphatidyl-inositol-3-phosphate kinase
(PI3K) phosphorylation [8,15] . Therefore, it is proposed that the
coupling of lipolysis and lipid uptake to oxidative capacity in
endurance-trained individuals limits the production of toxic lipid
intermediates and explains the obese and endurance-trained
paradox in insulin responsiveness. This hypothesis has not yet
been fully explored.
The activation of cAMP/PKA and calcium (Ca
2+) signaling
pathways is known to promote mitochondrial biogenesis and
increase lipid oxidation capacity in vivo [16,17,18]. Cell culture
systems using L6 myoblasts have been used effectively to study
glucose and lipid metabolism [19,20], and differentiated human
primary myotubes retain many of the metabolic characteristics of
mature skeletal muscle [21]. In the present study, we hypothesized
that activation of cAMP/PKA and Ca
2+ signaling pathways in
human primary myotubes would induce functional changes in
lipid metabolism and therefore improve insulin responsiveness. We
provide novel evidence that the PFI-induced cAMP/PKA and
Ca
2+ signaling pathways increase lipid oxidation, storage and
lipolysis, as well as improve insulin responsiveness in human
primary myotubes.
Materials and Methods
Skeletal muscle cell culture and treatment rationale
This study was approved by the Ethical Committee of
Pennington Biomedical Research Center. The study was con-
ducted according to the Declaration of Helsinki and in accordance
with the Medical Research Involving Human Participants Act.
The general principles of informed consent, ethics review and data
management were in line with GCP. All participants gave written
and verbal consent to all study procedures.
Samples of vastus lateralis from four young lean healthy insulin
sensitive male subjects (age 28.064.0 yrs, BMI 23.561.6 kg.m
22,
glucose disposal rate 12.660.7 mg.min
21.kg
21 as measured by a
euglycemic-hyperinsulinemic clamp) were obtained by muscle
biopsy using the Bergstrom technique [1]. Satellite cells (quiescent
mononuclear muscle cells) were isolated by trypsin digestion, pre-
plated on an uncoated petri dish for an hour to remove fibroblasts,
and subsequently transferred to T-25 collagen–coated flasks in
Dulbecco’s Minimum Essential Medium (DMEM) supplemented
with 16% Fetal Bovine Serum (FBS) and human growth factors.
Cells were passaged once, and mononuclear myoblasts were
immunopurified using the mouse monoclonal 5.1H11 anti-CD56
(also known as Neural Cell Adhesion Molecule 1) antibody [2]
(Developmental Studies Hybridoma Bank, Iowa City, IA). The
recovery of mononuclear myoblasts ranged from 10 to 20% of the
total cell count in the preparation. In order to eliminate any
genetic or epigenetic influence on the treatment responses, cells
from all four donors were pooled. Cells were grown at 37uCi na
humidified atmosphere of 5% CO2. Differentiation of myoblasts
into myotubes was initiated at approximately 90% confluence, by
switching to a-MEM with antibiotics, 2% FBS and fetuin for
maximal adhesion and growth [3]. The media was changed every
other day. During differentiation, cells were treated continuously
with 30 mM of palmitate (Sigma-Aldrich, St Louis, MO) and not
pulsed (control), or pulsed one hour per day for the last three days
of differentiation with a cocktail containing 4 mM of forskolin
(Calbiochem Corp., Darmstadt, Germany) and 0.5 mMo f
ionomycin (Sigma-Aldrich, St Louis, MO) (PFI), to activate
cAMP/PKA and Ca
2+ signaling pathways, respectively. Forskolin
(a PKA activator) and ionomycin (a calcium ionophore), known to
activate signaling pathways involved in response to exercise
(adrenergic and calcium signaling), are used here in pulse to
mimic a bout of exercise. Palmitate was coupled to BSA and then
dissolved in the media. The 30 uM palmitate concentration used
in our experiments is rather low and thus does not induce insulin
resistance. Much higher concentrations of palmitate (up to
400 uM) seem to be necessary to induce insulin resistance in
myotubes [6]. Pilot experiments for cellular toxicity determined
the optimal timing, duration and concentration of palmitate,
forskolin and ionomycin (data not shown). Previous evidence [4,5],
as well as our own preliminary data, has shown that lower
concentrations of palmitate are capable of increasing fat oxidative
capacity of muscle cells. This also explains its additive effect in
combination with the other two compounds. We did not measure
the PKA activity nor the activity of calcium-activated kinases;
nevertheless, based on the available evidence regarding these
cAMP- and calcium-stimulated pathways [7], the pulse treatment
in given concentrations should have an expected effect on relevant
signaling pathways. Previous evidence from our lab also
demonstrates the effects of these compounds separately, thus
further supporting the additive effect of the combination of the
compounds [22]. All experiments were performed after five days
of differentiation, when about 70–80% of mononuclear myoblasts
had fused to form multinuclear elongated myotubes. All
measurements were done in triplicate and across four independent
cultures.
Mitochondrial content and enzyme activity assay
Quantification of mitochondrial content was performed as
previously described using mtDNA copy number [23] and
Mitotracker Green probe
TM (Molecular Probes, Invitrogen,
Eugene, OR). The sequences for the primer/probe sets used in
TaqMan analysis of mtDNA content for NADH dehydrogenase
subunit 1 (ND1) and of nuclear DNA for lipoprotein lipase (LPL)
were designed using Primer Express version 2.1 (Applied
Biosystems-Roche, Branchburg, NJ) (Table S1). Mitotracker
Green probe preferentially accumulates in mitochondria regard-
less of the mitochondrial membrane potential and thus provides an
accurate assessment of mitochondrial mass [24]. Briefly, cells were
washed with 16PBS and incubated at 37uC for 30 minutes with
100 nM Mitotracker Green. Cells were then harvested using
trypsin/EDTA and re-suspended in 16 PBS. Fluorescence
intensity was detected with excitation and emission wavelengths
of 490 and 516 nm, respectively, and values corrected for total
protein (mg/ml). b-hydroxyacyl-CoA dehydrogenase (b-HAD)
and citrate synthase (CS) activities were determined spectropho-
tometrically from cell homogenates as previously described [25].
Lipid oxidation
Cells were pre-incubated for three hours with [1-
14C] palmitate
(1 mCi/ml; PerkinElmer, Boston, MA) and [1-
14C] oleate (1 mCi/ml;
PerkinElmer, Boston, MA) and respective non-labeled palmitate and
oleate (100 mM). Palmitate and oleate were coupled to a fatty acid
In Vitro Model of Lipid Metabolism
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14CO2 and
14ASM (acid soluble metabolites) were measured as previously
described [26]. Briefly, assayed media were transferred to a custom
made Teflon 48-well CO2 trapping plate that was clamped and
sealed. 70% perchloric acid was injected through the perforations in
the lid directly into the media, which drives CO2 through the tunnel
into an adjacent well where it was trapped in 1N NaOH. Following
CO2 trapping, the media were spun twice and
14ASM measured by
scintillation counting. Aliquots of NaOH and media were transferred
into scintillation vials, and radioactivity was measured on a
multipurpose scintillation counter (LS 6500; Beckman Coulter, Brea,
CA). All assays were performed in triplicates, and data were
normalized to protein content. The ratio of CO2:ASM represents
‘‘efficient’’ lipid oxidation, namely the ratio of lipid completely
oxidized to CO2 relative to those metabolites of the lipid that are not
completely oxidized to CO2,i nt h i sc a s eA S M .
Lipid synthesis
At the end of the lipid oxidation assay, cells were washed twice
with 16 PBS and harvested into 0.25 ml of 0.05% SDS for
subsequent protein measurement and total lipid extraction with
1 ml of chloroform/methanol (2v/1v). Lipids were washed with
70% ethanol and re-dissolved for thin layer chromatography
(TLC) (Anal Tech TLC plates, Whatman Ltd., Kent, ME) and run
in a mobile phase containing hexane/diethyl ether/acetic acid, v/
v/v, 80:20:1). Bands corresponding to phospholipids (PL),
diacylglycerol (DAG), and triacylglycerol (TAG) were scanned
and quantified using Win-Scan Version 3.12 software (Bioscan
Inc., Washington, DC).
Glucose oxidation
Cells were pre-incubated with a glucose- and serum-free media
for 90 minutes, followed by three hour incubation with D[U-
14C]
glucose (1 mCi/ml; PerkinElmer, Boston, MA) and 5.5 mM of
non-labeled glucose. After
14C glucose incubation,
14CO2 was
measured as described above in the ‘‘Lipid oxidation’’ methods
section.
Glucose uptake
Cells were grown and differentiated in 12-well plates.
Experimental conditions were as follows: 1 pmol/l, 1 nmol/l,
and 1 mmol/l insulin. Before determining glucose uptake, all cell
cultures were exposed to basal medium for 1 h. Wells were rapidly
washed three times at room temperature with reaction buffer:
150 mmol/l NaCl, 5 mmol/l KCl, 1.2 mmol/l MgSO4,
1.2 mmol/l NaH2PO4, 10 mmol/l HEPES, and 0.1% BSA,
pH 7.4, and then incubated in the same buffer supplemented
with 2-deoxyglucose (DOG)/2-[
3H]DOG (10 mmol/l final con-
centration, 0.2 mCi/well). For the determination of nonspecific
DOG uptake, control cultures were incubated with phloretin
(100 mg/ml). The reactions were stopped after 15 min by
aspirating the reaction mixture and rapidly rinsing each well four
times with PBS at 4uC. Cells were solubilized by the addition of
0.5 ml of 0.1 mol/l NaOH. An aliquot of 50 ml was removed for
protein determination. The remaining fluid was placed in 5 mL of
scintillation fluid. Glucose transport activity is expressed as
picomoles of DOG taken up per minute per milligram of total
protein.
Glycogen synthesis
Cells were exposed to DMEM supplemented with [2-
3H]
deoxyglucose (1 mCi/ml, PerkinElmer) and 500 mM non-labeled
glucose for four hours and with D[U-
14C] glucose (1 mCi/ml;
PerkinElmer) for four hours in the absence or presence of 100 nM
of insulin (Humulin, Eli Lilly, Indianapolis, IN) to study basal and
insulin-mediated glycogen, respectively, as previously described
[27]. Briefly, after rinsing each well twice with 16PBS at 4uC, the
cells were solubilized by the addition of 250 ml of 30% potassium
hydroxide (KOH). The samples were added to 35 ml of 60 mg/ml
glycogen (Sigma-Aldrich, St Louis, MO) in distilled water and
heated at 70uC for 20 minutes. Following incubation, 1 ml of ice-
cold 100% ethanol was added to precipitate glycogen. The tubes
were centrifuged (2000 g for 20 minutes at 4uC), and the
supernatant was immediately removed and discarded. After one
wash with 70% ethanol, the glycogen precipitate was re-suspended
in 500 ml distilled water, dissolved under shaking for 20 minutes
and counted by liquid scintillation (LS 6500; Beckman Coulter,
Brea, CA).
Lipolysis assay
Lipolysis was performed as previously described [28]. Briefly, at
day five of differentiation, cells were pre-incubated in serum-free
media for 90 minutes. The lipolysis assay was performed over
three hours by adding 0.25 ml of Hank’s Balanced Salt Solution
(HBSS)+2% Bovine Serum Albumin (BSA) without or with 1 mM
of isoproterenol hydrochloride (a non-selective b-adrenergic
agonist, Sigma-Aldrich, St Louis, MO). Fluorescence intensity of
glycerol was detected and values corrected for total protein (mg/
ml).
Immunocytochemistry and confocal imaging
Lipid droplets were visualized using Bodipy 493/503 (Invitro-
gen Molecular Probes, Eugene, OR). Nuclei were stained using
Table 1. Pathway analysis of PFI-induced gene activation in
human primary myotubes.
Biological Processes Up/Down p value
Protein metabolism and modification + ,0.0001
Protein phosphorylation + ,0.0001
Intracellular signaling + ,0.0001
Carbohydrate metabolism + ,0.0001
Signal transduction + ,0.0001
G-protein mediated signaling 2, 0.0001
Lipid, fatty acid and steroid metabolism + ,0.0001
Stress response + ,0.0001
Transport + ,0.0001
Steroid hormone metabolism 2, 0.0001
Serine/Threonine kinase signaling + ,0.0001
Oxidative phosphorylation + 0.00011
Electron transport + 0.00015
Muscle contraction + 0.00094
Lipid metabolism + 0.0014
Carbohydrate transport + 0.0028
Mitochondrial transport + 0.0038
Calcium-mediated signaling + 0.026
Fatty acid b-oxidation + 0.076
Data are expressed as mean 6 SEM of 4 separate experiments. + Indicate up-
regulation, - down-regulation of the biological processes in response to the PFI
treatment.
doi:10.1371/journal.pone.0021068.t001
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were stained as previously described [29]. Briefly, myotubes were
rinsed three times with 16 PBS, followed by fixing with 10%
formalin for one hour and permeabilization with 0.1% saponin for
20 minutes, and then incubated with the primary antibodies,
mouse anti-MHC I (Chemicon International Inc., Temecula, CA)
and mouse anti-MHC II (GeneTex Inc., San Antonio, TX), for
one hour at 25uC. Following three washes with 16 PBS plus
0.05% Tween 20, cells were incubated for one hour at 25uC with
secondary antibodies, goat anti-mouse IgG conjugated to Alexa-
680 (Invitrogen Molecular Probes, Eugene, OR). Proteins were
visualized by confocal microscopy (Zeiss LSM 510 Meta, Thorn-
wood, NY). Images were captured and analyzed using the Image J
version 1.37c software (NIH, USA). Negative controls performed
with the addition of a non-specific mouse primary IgG did not
present a fluorescent signal.
Real-time qRT-PCR
Total RNA from cultured myotubes was isolated with Trizol
reagent (Invitrogen, Carlsbad, CA). The quantity and integrity of
the RNA was confirmed with the Agilent 2100 Bioanalyzer
(Agilent Technologies, Palo Alto, CA). All primers and probes
were designed using Primer Express version 2.1 (Applied
Biosystems-Roche, Branchburg, NJ), and sequences are listed in
Table S1. Real-time quantitative RT-PCR reactions were
performed as one-step reactions in ABI PRISM 7900 (Applied
Biosystems) using the following parameters: one cycle of 48uC for
30 minutes, then 95uC for 10 minutes, followed by 40 cycles at
95uC for 15 seconds and 60uC for 1 minute. For all assays
performed using Taqman primers and probe, the ribosomal
phosphoprotein large P0 gene (RPLP0) was used as internal
control. All gene expression data were normalized by dividing the
target gene by the internal control.
Microarray
Near whole genome transcriptome analysis was performed
using the IlluminaTM bead based technology and Sentrix
Human-6 V2 Expression BeadChip (Part Number: BD-25-113;
Illumina Inc., San Diego, CA). Cell culture experiments were
performed in quadruplicate with duplicate well RNAs extracted
for each experiment. These eight RNA samples were assayed in
duplicate for a total of 16 near whole genome transcriptome
datasets. Raw data was imported into SAS v9.1 (SAS Inc., Cary,
NC) and low quality data, specifically probes not above
background or with high background intensities, were excluded
based on the Illumina platform scanning software metric
‘‘Detection Value’’ (p,0.05). MA plots were used to visualize
the transcriptome data pre- and post- normalization of the data.
Normalization of the raw data was accomplished using SAS code
written to implement a Quantile Normalization procedure as
described previously [25]. The significance of the fold change of
the treatment effect was tested for each gene using ANOVA
[PROC MIXED in SAS]. Also, two-sided False Discovery Rate
(FDR) was calculated for each gene with a cut point at p,0.05.
Using the complete hit list, a pathway analysis was generated using
PANTHER (www.pantherdb.org) and is presented in Table 1. All
Figure 1. Fatty acid oxidation. Cultured myotubes were incubated with 100 mM of [1-
14C] oleate (A) or [1-
14C] palmitate (B) for 3 h, and radiolabel
incorporation into CO2 was determined as a measure of complete fat oxidation (FAO). Radiolabel incorporation into acid soluble molecules (ASM) was
measured to assess incomplete FAO. The ratio of CO2 to ASM was calculated for oleate (C) and palmitate (D). Data are expressed as mean 6 SEM of 4
separate experiments. ** p,0.01, *** p,0.001 versus control.
doi:10.1371/journal.pone.0021068.g001
In Vitro Model of Lipid Metabolism
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compliant database such as the Gene Expression Omnibus (GEO)
[30], or CIBEX [31] as acceptable public repositories.
Statistical analyses
All statistical analyses were performed using GraphPad Prism
4.0 for Windows (GraphPad Software Inc., San Diego, CA). A
two-tailed t-test was performed to determine the effect of the PFI
treatment. Since all variables were normally distributed, correla-
tions were performed in a pairwise fashion using the Pearson
product moment statistic. All values in figures and tables are
presented as mean 6 SEM. Statistical significance was set at
p,0.05.
Results
Induction of mitochondrial oxidative capacity
The PFI treatment increased the complete oxidation of oleate
(2.7 fold, p,0.001) and palmitate (2.5 fold, p,0.001) (Fig. 1A & B)
as measured by
14CO2. Incomplete oxidation as measured by
14ASM (acid soluble metabolites) of palmitate (1.07460.020 vs.
1.70360.578 nmol/3 h/mg for control and PFI respectively,
p,0.001; data not shown) increased after PFI treatment and
trended toward a significant increase for oleate (0.41760.014 vs.
0.45760.013 nmol/3 h/mg for control and PFI respectively,
p=0.06; data not shown). Interestingly, the ratio of CO2 to
ASM for oleate (p,0.001; Fig. 1C) and palmitate (p,0.01;
Fig. 1D) increased. This ratio is a marker of efficient lipid
oxidation in that more CO2 is produced compared to ASM. As
previously reported, the capacity to completely oxidize oleate to
CO2 was higher than for palmitate (p,0.001) [32]. Mitochondrial
content and mass also increased as indicated by mtDNA (6 fold,
p,0.01) (Fig. 2A) and Mitotracker
TM Green (2 fold, p,0.001)
(Fig. 2B). b-HAD activity increased 1.6 fold (p,0.01); however,
the increase in CS activity (1.3 fold) did not reach significance
(Fig. 2C & D). Pathway analysis of the microarray gene expression
data further revealed an up-regulation of intracellular calcium-
signaling (p,0.05), serine/threonine kinase signaling (p,0.0001)
and signal transduction pathways (p,0.0001) as expected
(Table 1). Interestingly, carbohydrate (p,0.0001) and lipid
metabolism (p,0.01) pathways, as well as mitochondrial transport
(p,0.01), oxidative phosphorylation (p,0.001) and electron
transport chain (p,0.001) pathways, were also up-regulated in
response to the PFI treatment (Table 1). Confirming the additive
effect of the PFI treatment to mimic exercise, gene expressions
involved in muscle contraction were also up-regulated (p,0.001)
(Table 1). Activation of cAMP/PKA and Ca
2+ signaling pathways
with the PFI treatment also increased gene expression of two
transcription factors involved in the stimulation of mitochondrial
biogenesis, PGC-1a and PPARd by 3- and 2-fold, respectively
(Table 2); however, these changes failed to reach statistical
significance due to large variation.
Remodeling of lipid droplets
Confocal microscopy of lipid droplets (stained with Bodipy 493/
503) showed a diffuse pattern in lipid staining in control myotubes
(Fig. 3A & C). Importantly, PFI treatment caused an increase in
the organization of lipid droplets along the myofibrillar apparatus
Figure 2. Mitochondrial content and enzymes activity. (A) Mitochondrial content determined by mtDNA copy number. (B) Mitochondrial
content determined by Mitotracker Green FM. (C) b-hydroxyacyl-CoA dehydrogenase (b-HAD) activity adjusted for protein content. (D) Citrate
synthase (CS) activity adjusted for protein content. Data are expressed as mean 6 SEM of 4 separate experiments. ** p,0.01, *** p,0.001 versus
control.
doi:10.1371/journal.pone.0021068.g002
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staining of nuclei with DAPI (Fig. 3D). Image quantification
revealed an increase in the fluorescence signal in the PFI condition
compared to control suggesting an increase in intramyocellular
lipid content, together with a redistribution of the lipid droplets.
Interestingly, the remodeling of lipid droplets between myofibrils
was associated with large changes in the expression of lipid droplet
proteins. Two genes associated with lipid droplets were regulated
by the PFI treatment. Adipose differentiation related protein
(ADRP) gene expression was induced approximately 7-fold
(p,0.05) compared to baseline, while tail-interacting protein 47
(TIP47) gene expression was also increased (p=0.02) (Table 2).
Functional changes in lipid metabolism
In parallel to the remodeling of lipid droplets, we found
increased total lipid storage capacity (1.4 fold, p,0.05) in response
to oleate during the PFI treatment (Fig. 4A), which is consistent
with the increase in intramyocellular neutral lipid content as
evidenced above by the increase in the fluorescence signal in the
PFI condition compared to control. Interestingly, thin layer
chromatography analyses of lipid intermediates species revealed
increased triacylglycerol (TAG) synthesis (1.4 fold, p,0.05) after
PFI treatment without any changes in diacylglycerol (DAG) and
phospholipid (PL) synthesis (Fig. 4B). This increased lipid storage
capacity was in line with up-regulation of the glycerolipid
biosynthesis rate-limiting enzymes diacylglycerol o-acyltransferase
1 (DGAT1, p=0.01) and glycerol-3-phosphate acyltransferase
(GPAT, p,0.05) gene expression (Table 2). We also observed an
up-regulation of sterol regulatory binding protein 1 (SREBP1,
p=0.01) and fatty acid synthase (FASN, p,0.05), key factors in
the de novo lipogenesis pathway (Table 2). Lipolytic capacity
increased as reflected by a 4-fold increase in isoproterenol-
mediated glycerol release (p,0.01) (Fig. 4C). However, basal
lipolysis was not different between control and PFI conditions
(10.361.0 vs. 9.561.1 mmol/3 h/mg protein; data not shown).
Hormone-sensitive lipase (HSL) and comparative gene identifica-
tion-58 (CGI-58) gene expression, the rate-limiting enzyme of
lipolysis and a potent co-activator of adipose triacylglycerol lipase
(ATGL), respectively, were up-regulated (p,0.001 and p,0.01)
(Table 2).
Functional changes in glucose metabolism
Basal and insulin-stimulated glucose uptake did not differ
between the control and PFI treatment (data not shown).
However, baseline (1.3 fold, p,0.01) and maximal insulin-
stimulated (2.2 fold, p,0.01) glycogen storage increased after
the PFI treatment compared to control (Fig. 5A). The capacity of
insulin to promote glycogen storage at baseline was strongly
enhanced (2.1 fold, p,0.01) after the PFI treatment (Fig. 5B),
indicating an improvement in insulin responsiveness. Additionally,
glucose oxidation tended to increase (1.3 fold, p=0.14) and lactate
production tended to decrease (0.5 fold, p=0.09) after the PFI
treatment (data not shown) without reaching significance. These
data suggest a shift toward aerobic glucose metabolism. Across
experiments, we observed a tight correlation between the increase
in mitochondrial oxidative capacity for oleate (R=0.76, p=0.004)
and palmitate (R=0.70, p=0.01) and the increase in insulin
responsiveness based on glycogen storage (Table 3). We also found
a positive relationship between the increase in insulin responsive-
ness and the increase in lipid storage (R=0.73, p=0.007) and
lipolytic capacity (R=0.78, p=0.02) (Table 3).
Discussion
Cultured myotubes are a valuable tool for investigation of the
interactions between lipid and glucose metabolism. In the present
study, we utilized a novel pharmacological treatment to activate
cAMP/PKA and Ca
2+ signaling pathways in primary human
myotubes to investigate the impacts on the coordination of lipid
metabolism and insulin responsiveness in skeletal muscle. We
observed four key structural and functional changes: 1) an increase
in mitochondrial biogenesis, 2) an increase in lipid oxidation, 3) a
reorganization of lipid droplets and 4) an increase in insulin
responsiveness as measured by insulin-mediated glycogen synthe-
sis, comparable to those observed in vivo. Furthermore, these
results illustrate a tight relationship between oxidative capacity, an
organized lipid storage system and insulin responsiveness. This
model provides an avenue to enhance our knowledge of the
interrelationships of these four key cellular attributes.
Activation of cAMP/PKA and Ca
2+ signaling pathways is
involved in mitochondrial biogenesis [17,18,33,34] and improves
lipid oxidation at rest and during submaximal exercise [11,35].
Recent studies have identified critical transcription factors
mediating the effect of induction of these pathways at the cellular
level. Costford et al. compared the effects of exercise training in vivo
to that of the PFI cocktail and found that mitochondrial content
and NAMPT, an enzyme involved in the SIRT1-PGC-1a
mitochondrial biogenesis pathway, gene expression were increased
in both conditions [22]. PGC-1a and PPARd are major players in
the cAMP/PKA and Ca
2+ signaling cascade leading to mitochon-
drial biogenesis [33,34,36,37]. We found that pharmacological
activation of cAMP/PKA and Ca
2+ signaling pathways did in fact
induce PGC-1a and PPARd gene expression, although not
significantly due to variation, and mitochondrial content. In line
Table 2. Treatment of human primary myotubes with PFI
increases expression of several genes related to mitochondrial
biogenesis, lipolysis and lipid storage.
Genes Fold change P value
Mitochondrial biogenesis
PGC-1a 3.2760.93 NS
PPARd 2.0760.45 0.06
Lipolysis
HSL 1.4760.02 ,0.001
ATGL 1.1960.08 NS
CGI-58 1.8160.07 ,0.01
Lipid droplet proteins
ADRP 7.5162.19 ,0.05
TIP-47 0.6360.03 0.02
Lipid storage
DGAT1 1.3260.07 0.01
GPAT 1.7260.23 ,0.05
SREBP-1 0.6060.06 ,0.01
FASN 0.6160.06 ,0.05
Data are expressed as mean 6 SEM of 4 separate experiments. NS: not
significant. PGC-1a, peroxisome proliferator activated receptor coactivator-1 a;
PPARd, peroxisome proliferator activated receptor d; HSL, hormone sensitive
lipase; ATGL, adipose triglyceride lipase; CGI-58, comparative identification
gene 58; ADRP, adipose related differentiation protein; TIP-47, tail interacting
protein of 47 kDa; DGAT1, diacylglycerol acyl-transferase 1; GPAT, glycerol-3-
phosphate acyl-transferase; SREBP-1, sterol responsive element binding protein-
1; FASN, fatty acid synthase.
doi:10.1371/journal.pone.0021068.t002
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higher lipid oxidation for both oleate and palmitate and increased
the activity of the rate-limiting enzyme of the b-oxidation
pathway, b-HAD. Recent data from Koves et al. [38] suggests
that the mismatch between b-oxidation and complete mitochon-
drial oxidation generates intermediate products that are critical to
the development of insulin resistance. Our results show that PFI-
activated myotubes exhibited higher rates of complete oxidation to
CO2, reflecting enhanced coupling of mitochondrial b-oxidation
to the electron transport chain, which was accompanied by an
improvement in insulin responsiveness for glycogen storage. By
increasing mitochondrial content and the lipid oxidation machin-
ery efficiency, PFI treatment couples b-oxidation to complete
mitochondrial oxidation. Notably, while the complete oxidation to
CO2 is similar for both palmitate and oleate, the ratio of
CO2:ASM is higher for oleate, thus indicating lower ASMs. This is
likely due to the fact that acutely oleate is more readily stored than
palmitate [39] and therefore produces less ASMs.
These ex vivo results with the novel PFI treatment are similar to
the effects of exercise training in skeletal muscle, which is also
known to activate the cAMP/PKA and Ca
2+ signaling pathways,
along with various others. For example, Tarnoplosky et al found
that 7 weeks of aerobic training in lean young men and women
increased the number of lipid droplets and changed their
intracellular distribution within the muscle. Transmission electron
micrograph revealed a reorganization of lipid droplets along the
myofibrillar apparatus, as well as an increase in their physical
contact with mitochondria [35]. Those functional changes in
intramyocellular lipid (IMCL) distribution were associated with
increased total mitochondria area and capacity for lipid oxidation
during exercise. In the present study, the PFI treatment increased
the number of lipid droplets along the myofibrillar apparatus, as
well as in the perinuclear region where the triacylglycerols are
thought to be packaged [40]. Interestingly, these changes in lipid
droplet distribution were closely associated with changes in lipid
droplet protein (ADRP and TIP-47) gene expression. In a recent
study by Prats et al., ADRP and TIP-47 were identified as the
main lipid droplet proteins associated with intramyocellular
triacylglycerol (IMTG) in rat skeletal muscle [41]. They showed
that epinephrine or electrical stimulation of isolated single muscle
fibers reduced IMTG content and translocated HSL to ADRP and
IMTG. We also observed a higher lipolytic response to
isoproterenol after activation of cAMP/PKA and Ca
2+ signaling
pathways in cultured myotubes. This enhanced lipolytic capacity
was related to higher expression of the lipases HSL and CGI-58.
HSL is thought to be a major lipolytic enzyme in skeletal muscle
[42,43,44]. CGI-58 has been identified as a potent co-activator of
ATGL, another lipase responsible for triacylglycerol breakdown in
murine and human adipose [45,46,47] and skeletal muscle tissue
[48]. Based on our results, CGI-58 could also play an important
role in the regulation of IMTG breakdown in human skeletal
muscle.
Lastly, another important facet of skeletal muscle lipid
metabolism is lipid storage capacity. In a recent report, Schenk
and Horowitz have shown that a single bout of exercise
(90 minutes at 65% of VO2 peak) is sufficient to improve lipid
storage capacity in skeletal muscle by partitioning more fatty acids
toward triacylglycerol synthesis [49]. This increased IMTG
storage capacity was associated with higher protein levels of
GPAT and DGAT1 in human skeletal muscle. We found
Figure 3. Confocal microscopy of lipid droplets. Lipid droplets were stained with Bodipy 493/503 (green) and nuclei were stained with DAPI
(blue). Note the increase in the organization of lipid droplets along the myofibrillar apparatus in panels B (206) and D (406) upon PFI treatment.
doi:10.1371/journal.pone.0021068.g003
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PFI treatment. This was accompanied by a higher gene expression
of rate-limiting enzymes of lipid synthesis including GPAT and
DGAT1. While we did not measure the identity of all the lipid
species other than triacylglycerol, diacylglycerol and phospholipid,
several studies support the idea that increased skeletal muscle lipid
storage and/or DGAT1 activity is protective against lipid-induced
insulin resistance by channeling more fatty acids into the
triacylglycerol pool and reducing the production of bioactive
‘‘lipotoxic’’ compounds altering insulin signaling and glucose
Figure 4. Lipid storage and lipolytic capacity. (A) Cultured myotubes were incubated with 100 mM [1-
14C] oleate for 3 h, then the cells were
harvested and total lipid extracted. Total lipid synthesis was measured as incorporation of radiolabel into total cellular lipids. (B) Lipid intermediates
species such as phospholipids (PL), diacylglycerol (DAG), and triacylglycerol (TAG) rates of synthesis were measured by thin-layer chromatography. (C)
Lipolysis measured as glycerol release was determined by subtracting baseline values to values during the stimulation with 1 mM of isoproterenol (a
non-selective b-adrenergic agonist). The graph represents the changes in lipolysis at baseline in response to isoproterenol in control and PFI
conditions. Data are expressed as mean 6 SEM of 4 separate experiments. * p,0.05, ** p,0.01 versus control.
doi:10.1371/journal.pone.0021068.g004
Figure 5. Glucose metabolism and insulin sensitivity. (A) Incorporation of [U-
14C] glucose into glycogen was measured in either the absence
(open bar) or the presence (black bar) of 100 nM of insulin. ** p,0.01 versus baseline,
{ p,0.05 versus control. (B) Insulin-stimulated glycogen
storage was measured by the change in glycogen storage at baseline in response to insulin and used as a marker of insulin responsiveness in this
model. Data are expressed as mean 6 SEM of 4 separate experiments. ** p,0.01 versus control.
doi:10.1371/journal.pone.0021068.g005
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rather than diacylglycerol or phospholipid is sufficient to support
this notion.
Together with structural changes in lipid droplet morphology
and functional changes in lipid metabolism, the PFI treatment
increased basal- and insulin-stimulated glycogen storage capacity
(i.e. non-oxidative glucose disposal). Insulin-mediated glucose
transport into muscle is the rate-controlling step for insulin-
stimulated muscle glycogen synthesis [3]. As such, insulin-
stimulated glycogen storage is a relevant marker of insulin
responsiveness. Furthermore, myotubes have a high basal
expression of Glut1 and Glut4 and thus a high basal glucose
uptake; therefore, it is not surprising that we did not observe a
detectable difference in basal or insulin-stimulated glucose uptake
between the control and the PFI treatment. In this model, changes
in oxidative capacity, lipid storage capacity and lipolytic capacity
are each closely associated with improvement in insulin respon-
siveness. Interestingly, these components of lipid metabolism are
all rate-limiting steps in IMTG turnover. The reorganization of
IMTG may channel lipids into oxidation and away from the
generation of ‘‘lipotoxic’’ intermediates.
It is important to note that other effects of forskolin, ionomycin
and/or their combination could indirectly influence the outcomes
we measured. While we did not measure the activity of signaling
pathways known to be activated by forskolin or ionomycin,
evidence from similar studies on the effects of palmitate and other
fatty acids on these signaling pathways [19,20], as well as our in-
depth examination of the functional metabolic outcomes, suggests
that these agents in combination did indeed lead to the effects
presented in this paper.
In summary, we have demonstrated that the activation of
cAMP/PKA and Ca
2+ signaling pathways with a novel pharma-
cological treatment results in a change in the intracellular
distribution of lipid droplets, functional changes in lipid synthesis,
lipolysis and lipid oxidation, as well as insulin-mediated glycogen
storage. This model provides important insights into the regulation
of lipid metabolism and insulin responsiveness in a cell culture
system. We also characterize a more physiologically relevant ex vivo
model of muscle lipid metabolism, which can be genetically
manipulated and intensely studied to further dissect complex
relationships between the organization of lipid droplets, mito-
chondrial oxidative capacity and insulin responsiveness, especially
in obesity and disease states such as type 2 diabetes.
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